This is a synthetic peptide designed for use in combination with anti-IRF2 antibody (Catalog #: P100943_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
IRF2
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
IRF2
(Interferon Regulatory Factor 2 (IRF2))
Hintergrund
IRF2 is a member of the interferon regulatory transcription factor (IRF) family. IRF2 competitively inhibits the IRF1-mediated transcriptional activation of interferons alpha and beta, and presumably other genes that employ IRF1 for transcription activation. However, IRF2 also functions as a transcriptional activator of histone H4.
Alias Symbols: IRF-2
Protein Interaction Partner: CSNK2A1,EP300,HMGB1,HMGN1,IRF2BP1,IRF2BP2,IRF8,KAT2B,NFKB1,RELA,STAT1,BRD7,CSNK2A1,EP300,IRF8,KAT2A,KAT2B,NFKB1,PRKACA,RELA